Increased MET expression and HGF-dependent invasion under hypoxia has been described years ago and has been subsequently confirmed by other studies conducted in several model systems, including glioblastoma and pancreatic cancer [12–14]. This evidence concerns the gene MET and pancreatic neoplasm.